Recent News

• 09.17.2025 - Unlocking the potential of GLP-1 based therapies with RWE
• 09.16.2025 - ICON’s new CEO champions AI and efficiency during industry’s ‘pivotal time’
• 09.12.2025 - Cardiovascular outcomes trials revisited – methodological enhancements for greater clinical relevance.
• 09.12.2025 - Preparing For The Biosimilar Era Of ADCs And BsAbs In Oncology
• 09.11.2025 - Deutsche Bank 2025 Healthcare Summit
• 09.11.2025 - Deutsche Bank 2025 Healthcare Summit
• 09.10.2025 - September 10, 2025 1:25 PM EDT - September 10, 2025 : Baird 2025 Global Healthcare Conference
• 09.10.2025 - September 10, 2025 1:25 PM EDT - September 10, 2025 : Baird 2025 Global Healthcare Conference
• 09.04.2025 - ICON Announces CEO Transition
• 09.04.2025 - ICON Announces CEO Transition

Recent Filings

• 09.04.2025 - EX-99.1 EX-99.1
• 09.04.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 09.04.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 09.04.2025 - EX-99.1 EX-99.1